Besides following our news, follow us on socials networks :
Strategic partnership with Champions Oncology, Inc
TransCure bioServices SAS was selected for the SME instruments call-to-offer Phase 1 with 273 companies out of 2’822 applicants.
TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer
INSERM publishes first in vivo proof of concept of an engineered Chimeric Antigen Receptor T cell directed against IL-1RAP expressed by leukemia stem cells using TransCure’s full human immune system hu-mouse models.
Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.
TransCure bioServices hires Benjamin TSCHUMI – New Deputy Project Officer